Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs metronidazole for Helicobacter pylori eradication
IRCT20240311061259N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levofloxacin and metronidazole in Helicobacter pylori infection (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: H. pylori eradication rate. Started Oct 2024; status: completed.
02
Drugs
levofloxacinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20240311061259N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240311061259N1.